Obesity Treatment Market Size & Forecast, By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) And Trend Report

Obesity Treatment Market Size & Forecast, By Drugs (Combination Drugs, Appetite Suppressants, Malabsorption & Satiety Drugs), By Surgery & Devices (Adjustable Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve Gastrectomy, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures) And Trend Analysis To 2024

  • Published Date: Sep, 2016
  • Base Year for Estimate: 2015
  • Report ID: GVR-1-68038-095-8
  • Format: Electronic (PDF)
  • Historical Data: 2013-2015
  • Number of Pages: 80

Table of Contents

Chapter 1 Research Methodology
                   1.1 Information Procurement
                   1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
                   4.1 Market Segmentation & Scope
                      4.1.1 Market Driver Analysis
                            4.1.1.1. Growing global prevalence of obesity
                            4.1.1.2. Changing lifestyles and food habits
                            4.1.1.3. Demand for minimally invasive procedures
                            4.1.1.4. Rising awareness about the different bariatric surgeries
                      4.1.2 Market Restraint Analysis
                            4.1.2.1.Complexities related to obesity treatment
                            4.1.2.2.High cost associated to surgeries
                            4.1.2.3. Limited insurance coverage
                   4.2 Obesity Treatment Market - SWOT Analysis
                   4.3 Industry Analysis - Porter’s
Chapter 5 Market Categorization 1: Product Estimates & Trend Analysis
                   5.1.Obesity Treatment Market: Product Movement Analysis
                      5.1.1. Combination drugs
                      5.1.2. Appetite suppressants
                      5.1.3. Malabsorption
                      5.1.4. Satiety
Chapter 6 Market Categorization 2: Surgery & Devices Estimates & Trend Analysis
                   6.1. Obesity Treatment Market: Surgery & Devices Movement Analysis
                      6.1.1. Adjustable gastric banding
                      6.1.2. Roux-en-Y gastric bypass
                      6.1.3. Sleeve gastrectomy
                      6.1.4. Biliopancreatic diversion with duodenal switch
                      6.1.5. Endoscopic procedures
                      6.1.6. Others
Chapter 7 Market Categorization 2: Regional Estimates & Trend Analysis, by Product
                   7.1. North America
                      7.1.1. The U.S.
                      7.1.2.Canada
                   7.2. Europe
                      7.2.1 The U.K.
                      7.2.2. Germany
                      7.2.3 Asia Pacific
                            7.2.3.1 Japan
                            7.2.3.2 China
                      7.2.4 Latin America
                            7.2.4.1 Brazil
                            7.2.4.2 Mexico
                      7.2.5 MEA
                            7.2.5.1 South Africa
Chapter 8 Competitive Landscape
                   8.1 Strategy framework
                   8.2 Market participation categorization
                   8.3 Company Profiles
                      8.3.1 VIVUS, Inc.
                            8.3.1.1 Company overview
                            8.3.1.2 Financial performance
                            8.3.1.3 Product benchmarking
                            8.3.1.4 Strategic initiatives
                      8.3.2 Arena Pharmaceuticals, Inc.
                            8.3.2.1 Company overview
                            8.3.2.2 Financial performance
                            8.3.2.3 Product benchmarking
                            8.3.2.4 Strategic initiatives
                      8.3.3 F. Hoffmann-La Roche, Ltd.
                            8.3.3.1 Company overview
                            8.3.3.2 Financial performance
                            8.3.3.3 Product benchmarking
                            8.3.3.4 Strategic initiatives
                      8.3.4 Novo Nordisk A/S
                            8.3.4.1 Company overview
                            8.3.4.2 Financial performance
                            8.3.4.3 Product benchmarking
                            8.3.4.4 Strategic initiatives
                      8.3.5 Orexigen Therapeutics, Inc.
                            8.3.5.1 Company overview
                            8.3.5.2 Financial performance
                            8.3.5.3 Product benchmarking
                            8.3.5.4 Strategic initiatives
                      8.3.6 Allergan
                            8.3.6.1 Company overview
                            8.3.6.2 Financial performance
                            8.3.6.3 Product benchmarking
                            8.3.6.4 Strategic initiatives
                      8.3.7 Cousin Biotech
                            8.3.7.1 Company overview
                            8.3.7.2 Financial performance
                            8.3.7.3 Product benchmarking
                            8.3.7.4 Strategic initiatives
                      8.3.8 EnteroMedics, Inc.
                            8.3.8.1 Company overview
                            8.3.8.2 Financial performance
                            8.3.8.3 Product benchmarking
                            8.3.8.4 Strategic initiatives
                      8.3.9 Ethicon ( Subsidiary of Johnson & Johnson)
                            8.3.9.1 Company overview
                            8.3.9.2 Financial performance
                            8.3.9.3 Product benchmarking
                            8.3.9.4 Strategic initiatives
                      8.3.10 Medtronic
                            8.3.10.1 Company overview
                            8.3.10.2 Financial performance
                            8.3.10.3 Product benchmarking
                            8.3.10.4 Strategic initiatives
                      8.3.11 USGI Medical, Inc.
                            8.3.11.1 Company overview
                            8.3.11.2 Financial performance
                            8.3.11.3 Product benchmarking
                            8.3.11.4 Strategic initiatives
                      8.3.12 Mediflex Surgical Products
                            8.3.12.1 Company overview
                            8.3.12.2 Financial performance
                            8.3.12.3 Product benchmarking
                            8.3.12.4 Strategic initiatives


List of Tables

TABLE 1 Anti-Obesity Products and cost per month
TABLE 2 North America obesity treatment market, 2014 - 2024 (USD Million)
TABLE 3 North America obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 4 North America obesity treatment market, by surgery, & devices 2014 - 2024 (USD Million)
TABLE 5 U.S. obesity treatment market, 2014 - 2024 (USD Million)
TABLE 6 U.S. obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 7 U.S. obesity treatment market, by surgery & devices 2014 - 2024 (USD Million)
TABLE 8 Canada obesity treatment market, 2014 - 2024 (USD Million)
TABLE 9 Canada obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 10 Canada obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 11 Europe obesity treatment market, 2014 - 2024 (USD Million)
TABLE 12 Europe obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 13 Europe obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 14 U.K. obesity treatment market, 2014 - 2024 (USD Million)
TABLE 15 U.K. obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 16 U.K. obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 17 Germany obesity treatment market, 2014 - 2024 (USD Million)
TABLE 18 Germany obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 19 Germany obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 20 Asia Pacific obesity treatment market, 2014 - 2024 (USD Million)
TABLE 21 Asia Pacific obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 22 Asia Pacific obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 23 Japan obesity treatment market, 2014 - 2024 (USD Million)
TABLE 24 Japan obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 25 Japan obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 26 China obesity treatment market, 2014 - 2024 (USD Million)
TABLE 27 China obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 28 China obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 29 Latin America obesity treatment market, 2014 - 2024 (USD Million)
TABLE 30 Latin America obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 31 Latin America obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 32 Brazil obesity treatment market, 2014 - 2024 (USD Million)
TABLE 33 Brazil obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 34 Brazil obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 35 Mexico obesity treatment market, 2014 - 2024 (USD Million)
TABLE 36 Mexico obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 37 Mexico obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 38 MEA obesity treatment market, 2014 - 2024 (USD Million)
TABLE 39 MEA obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 40 MEA obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)
TABLE 41 South Africa obesity treatment market, 2014 - 2024 (USD Million)
TABLE 42 South Africa obesity treatment market, by drugs, 2014 - 2024 (USD Million)
TABLE 43 South Africa obesity treatment market, by surgery & devices, 2014 - 2024 (USD Million)


List of Figures

FIG. 1 Market Research Process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 Market Summary (USD Million)
FIG. 7 Market trends & outlook
FIG. 8 Market segmentation & scope
FIG. 9 Market driver relevance analysis (Current & future impact)
FIG. 10 Prevalence of national physical inactivity and sedentary behaviors from 2003 - 2013
FIG. 11 Number of bariatric surgeries performed from 2007 - 2014
FIG. 12 Market restrainers relevance analysis (Current & future impact)
FIG. 13 Cost of bariatric surgical procedures (USD) in 2015
FIG. 14 SWOT analysis
FIG. 15 Porter’s five forces analysis
FIG. 16 Obesity treatment market Product outlook key takeaways
FIG. 17 Obesity treatment: Drugs movement analysis
FIG. 18 Global combination drugs market, 2012 - 2024 (USD Million)
FIG. 19 Global appetite suppressants market, 2012 - 2024 (USD Million)
FIG. 20 Global malabsorption market, 2012 - 2024 (USD Million)
FIG. 21 Global satiety market, 2012 - 2024 (USD Million)
FIG. 22 Obesity treatment market: Surgery & devices outlook key takeaways
FIG. 23 Obesity treatment: Surgery & devices movement analysis
FIG. 24 Global adjustable gastric banding market, 2012 - 2024 (USD Million)
FIG. 25 Global roux-en-Y gastric bypass market, 2012 - 2024 (USD Million)
FIG. 26 Global sleeve gastrectomy market, 2012 - 2024 (USD Million)
FIG. 27 Global billiopancreatic diversion with duodenal switch Market, 2012 - 2024 (USD Million)
FIG. 28 Global endoscopic Procedures Market, 2012 - 2024 (USD Million)
FIG. 29 Global others Market, 2012 - 2024 (USD Million)
FIG. 30 Regional market place: Key takeaways
FIG. 31 Strategy Framework
FIG. 32 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.